BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 35022030)

  • 1. The role of m6A RNA methylation in cancer metabolism.
    An Y; Duan H
    Mol Cancer; 2022 Jan; 21(1):14. PubMed ID: 35022030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m
    Uddin MB; Wang Z; Yang C
    Mol Cancer; 2021 Apr; 20(1):61. PubMed ID: 33814008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of m6A modifications on signaling pathways in human cancer (Review).
    Liu F; Su X
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into the interplay between m
    Yi YC; Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between m6A modification and miRNAs in malignant tumors.
    Han X; Guo J; Fan Z
    Cell Death Dis; 2021 Jun; 12(6):598. PubMed ID: 34108450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of m6A RNA methylation in cancer.
    Sun T; Wu R; Ming L
    Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.
    Wang Z; Zhang YX; Shi JZ; Yan Y; Zhao LL; Kou JJ; He YY; Xie XM; Zhang SJ; Pang XB
    Hypertens Res; 2024 May; 47(5):1273-1287. PubMed ID: 38438725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
    Cai X; Liang C; Zhang M; Xu Y; Weng Y; Li X; Yu W
    Cancer Lett; 2022 Sep; 544():215815. PubMed ID: 35798087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of RNA m
    Li Y; Huang H; Wu S; Zhou Y; Huang T; Jiang J
    Curr Gene Ther; 2023; 23(1):51-59. PubMed ID: 36043793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A RNA methylation regulates mitochondrial function.
    Kahl M; Xu Z; Arumugam S; Edens B; Fischietti M; Zhu AC; Platanias LC; He C; Zhuang X; Ma YC
    Hum Mol Genet; 2024 May; 33(11):969-980. PubMed ID: 38483349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
    Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A modification in RNA: biogenesis, functions and roles in gliomas.
    Zhang Y; Geng X; Li Q; Xu J; Tan Y; Xiao M; Song J; Liu F; Fang C; Wang H
    J Exp Clin Cancer Res; 2020 Sep; 39(1):192. PubMed ID: 32943100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.